Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence Reporting Assessment Score-Reference-Cited by-同舟云学术

Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence Reporting Assessment Score

Published:2022-08 Issue:2 Volume:304 Page:342-350
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Pecoraro Martina^ORCID,Turkbey Baris^ORCID,Purysko Andrei S.^ORCID,Girometti Rossano^ORCID,Giannarini Gianluca^ORCID,Villeirs Geert^ORCID,Roberto Michela,Catalano Carlo^ORCID,Padhani Anwar R.^ORCID,Barentsz Jelle O.^ORCID,Panebianco Valeria^ORCID

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.212252

Reference30 articles.

1. Mottet N , Cornford P , van den Bergh RCN , Briers E , De Santis M , Fanti S . EAU Guidelines: Prostate Cancer . Arnhem, the Netherlands: EAU Guidelines Office, 2021 .

2. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I

3. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II

4. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021

5. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging assessment of prostate cancer recurrence: advances in detection of local and systemic relapse;Abdominal Radiology;2024-09-10

2. Evaluación de la tasa de detección de la recidiva local y de cuerpo completo mediante la valoración integrada de la PET/RM con [18F]F-PSMA-1007 de pacientes con cáncer de próstata tratados con prostatectomía con recidiva bioquímica muy baja (< 0,5 ng/ml). Implicaciones terapéuticas;Revista Española de Medicina Nuclear e Imagen Molecular;2024-09

3. To evaluate the detection rate of local and whole-body recurrence by integrated [18F]F-PSMA-1007 PET/MR assessment of prostate cancer patients treated with prostatectomy with very low biochemical recurrence (<0.5 ng/ml). Therapeutic implications;Revista Española de Medicina Nuclear e Imagen Molecular (English Edition);2024-09

4. Rationale for adopting a combination of monoparametric MRI with the prostate-specific antigen in detecting clinically significant prostate cancer: comparison with standard biparametric and multiparametric MRI;British Journal of Radiology;2024-08-30

5. Protecting Prostate Cancer Classification From Rectal Artifacts via Targeted Adversarial Training;IEEE Journal of Biomedical and Health Informatics;2024-07